Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 945 | 244.7881 | 231,325 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 300 | 245.6867 | 73,706 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 224 | 243.245 | 54,487 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,000 | 218.9945 | 218,994 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 100 | 219.9 | 21,990 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,100 | 217.8553 | 239,641 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 721 | 216.9838 | 156,445 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,804 | 214.6815 | 387,285 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 375 | 216.0836 | 81,031 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,363 | 212.8513 | 290,116 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 5,009 | 211.844 | 1,061,127 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 8,827 | 210.9926 | 1,862,432 | D |
23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
11 Sep 2024 21:51 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SIBOLD WILLIAM JOHN | President and CEO | 09 Sep 2024 | Sale | 6,363 | 243.83 | 1,551,490 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)